Precision Oncology at UNIFONTIS: Insights from Prof. Drevs’ Interview at the Calm Over Cancer Summit

At UNIFONTIS Cancer Center, we are dedicated to pioneering a new era of individualized cancer care. In a recent in-depth interview at the Calm Over Cancer Summit, our founder and medical director, Professor Joachim Drevs, MD, discussed how precision oncology and immunotherapy are transforming cancer outcomes for patients worldwide. This conversation, hosted by Adele Kulyk, founder of Calm Over Cancer, offered valuable guidance and hope for anyone facing a cancer diagnosis.
Key Takeaways from Prof. Drevs’ Interview
During the summit session, Professor Drevs shared his expertise on what happens when standard cancer treatments stop working. He explained how, at UNIFONTIS, they uses advanced diagnostics like liquid biopsy and molecular profiling to identify new, actionable targets for therapy. These innovative techniques allow them to personalize treatment plans, ensuring that each patient receives care tailored to the unique characteristics of their cancer.
Professor Drevs also highlighted the powerful role of immunotherapy and therapeutic cancer vaccines. In the interview, he described how personalized vaccines, created from a patient’s own tumor cells, can activate the immune system and provide new hope, even when conventional therapies have been exhausted. This approach reflects our belief at UNIFONTIS: every cancer is unique, and every patient deserves a customized strategy.
Making Advanced Care Accessible and Compassionate
A central theme of the interview was the economic and ethical realities behind access to precision diagnostics and therapies. Professor Drevs emphasized the commitment at UNIFONTIS of making cutting-edge treatments available to all patients, regardless of background. We also recognize that maintaining quality of life is essential. That’s why we incorporate metronomic (low-dose) chemotherapy, aspirin protocols, and supportive care measures to minimize side effects and help patients live as fully as possible.
Why UNIFONTIS?
With over 30 years of experience, Professor Drevs and the UNIFONTIS team have established one of Europe’s most advanced private oncology clinics. Our guiding principle is simple: deliver hope through science, and precision through data. By participating in global conversations like the Calm Over Cancer Summit, we remain at the forefront of innovation - always focused on what matters most: our patients. If you missed the interview, we invite you to watch it here to learn more about our approach and the future of individualized cancer care.
For further information or to connect with our team, visit UNIFONTIS Cancer Center. Let us be your partner in hope and healing.

